These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1838041)

  • 21. Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.
    Ashizawa N; Yoshida M; Sugiyama Y; Akaike N; Ohbayashi S; Aotsuka T; Abe N; Fukushima K; Matsuura A
    Jpn J Pharmacol; 1997 Feb; 73(2):133-44. PubMed ID: 9074947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NADPH-oxidising activity in lens and erythrocytes in diabetic and nondiabetic patients with cataract.
    Crabbe MJ; Bron AJ; Peckar CO; Petchey M; Ting HH; Howard-Williams J
    Br J Ophthalmol; 1983 Oct; 67(10):696-9. PubMed ID: 6412739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II--a clinical research center study.
    Ratliff DM; Vander Jagt DJ; Eaton RP; Vander Jagt DL
    J Clin Endocrinol Metab; 1996 Feb; 81(2):488-92. PubMed ID: 8636255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy.
    Ziegler D; Mayer P; Rathmann W; Gries FA
    Diabetes Res Clin Pract; 1991 Oct; 14(1):63-73. PubMed ID: 1748064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical nerve dysfunction in children and adolescents with IDDM.
    Hyllienmark L; Brismar T; Ludvigsson J
    Diabetologia; 1995 Jun; 38(6):685-92. PubMed ID: 7672490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythrocyte aldose reductase protein: a clue to elucidate risk factors for diabetic neuropathies independent of glycemic control.
    Takahashi Y; Tachikawa T; Ito T; Takayama S; Omori Y; Iwamoto Y
    Diabetes Res Clin Pract; 1998 Nov; 42(2):101-7. PubMed ID: 9886746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldose reductase and diabetic retinopathy.
    Singh R; Dash D; Ansari FJ; Maurya OP; Singh VP
    Ann Ophthalmol; 1992 Nov; 24(11):420-2. PubMed ID: 1476398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldose reductase inhibitors and diabetic complications.
    Raskin P; Rosenstock J
    Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
    [No Abstract]   [Full Text] [Related]  

  • 29. Overt diabetic neuropathy: repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity.
    Sima AA; Prashar A; Nathaniel V; Bril V; Werb MR; Greene DA
    Diabet Med; 1993 Mar; 10(2):115-21. PubMed ID: 8458187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat.
    Ao S; Shingu Y; Kikuchi C; Takano Y; Nomura K; Fujiwara T; Ohkubo Y; Notsu Y; Yamaguchi I
    Metabolism; 1991 Jan; 40(1):77-87. PubMed ID: 1898618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy.
    Bril V; Buchanan RA
    Diabetes Care; 2004 Oct; 27(10):2369-75. PubMed ID: 15451902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
    Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ
    Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased levels of aldose reductase in peripheral mononuclear cells from type 2 diabetic patients with microangiopathy.
    Hasegawa G; Obayashi H; Kitamura A; Hashimoto M; Shigeta H; Nakamura N; Kondo M; Nishimura CY
    Diabetes Res Clin Pract; 1999 Aug; 45(1):9-14. PubMed ID: 10499880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
    Bhadada SV; Vyas VK; Goyal RK
    Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].
    Brogard JM; Caro-Sampara F; Blicklé JF
    Rev Med Interne; 1992; 13(1):69-79. PubMed ID: 1410879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacology of aldose reductase inhibitors.
    Kador PF; Robison WG; Kinoshita JH
    Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan.
    Hotta N; Sakamoto N; Shigeta Y; Kikkawa R; Goto Y
    J Diabetes Complications; 1996; 10(3):168-72. PubMed ID: 8807467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine.
    Kawai T; Takei I; Tokui M; Funae O; Miyamoto K; Tabata M; Hirata T; Saruta T; Shimada A; Itoh H
    J Diabetes Complications; 2010; 24(6):424-32. PubMed ID: 19716319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does aldose reductase have a role in the development of the ocular complications of diabetes?
    Lightman S
    Eye (Lond); 1993; 7 ( Pt 2)():238-41. PubMed ID: 7607342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The level of erythrocyte aldose reductase: a risk factor for diabetic neuropathy?
    Ito T; Nishimura C; Takahashi Y; Saito T; Omori Y
    Diabetes Res Clin Pract; 1997 Jun; 36(3):161-7. PubMed ID: 9237782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.